UNSPSC 85811820: Introduction of oxazolidinones into cranial cavity and brain, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into cranial cavity and brain, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0Q328

UNSPSC 85811820 Introduction of oxazolidinones into cranial cavity and brain, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The code's highly specialized medical procedure scope—a neurosurgical intervention involving intracranial drug delivery—does not match the healthcare services actually being solicited by state and local government bodies. Recent opportunities posted under or near this code instead cover telehealth services, occupational health exams, cancer screening, nursing home operations, behavioral health programs, EMS staffing, and various clinical support services—none of which involve oxazolidinone administration or neurosurgical placement. The mismatch suggests either miscoding of opportunities in state and local procurement systems or dormancy of this particular procedure code in the state and local market.

State and local healthcare procurement spans dozens of active categories—from urgent care and employee wellness platforms to opioid-recovery services and crisis stabilization—but this code does not appear to represent buying activity under current market conditions. Business development professionals tracking this code should verify whether it reflects genuine state and local demand or represents a misaligned taxonomy entry in the jurisdictions' procurement databases.